Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark G. Scher"'
Autor:
Suzanne L. Elliott, Lin-Fa Wang, Mark G. Scher, Ina Smith, Christopher J. de Bakker, Heidi J Carroll, Stephen M. Mahler, Paul M. Griffin, Martina L. Jones, Michael Gerometta, E.G. Playford, Benjamin S. Hughes, Christopher C. Broder, Kathleen D. Lynch, Reuben Klein, Kym Hoger, Edwin P. Huang, Dimiter S. Dimitrov, Stephen B. Lambert, Trent P. Munro, Karen Hughes, Margaret E. Gilmour, Debra El Saadi, Peter P. Gray
Publikováno v:
The Lancet Infectious Diseases. 20:445-454
Summary Background The monoclonal antibody m102.4 is a potent, fully human antibody that neutralises Hendra and Nipah viruses in vitro and in vivo. We aimed to investigate the safety, tolerability, pharmacokinetics, and immunogenicity of m102.4 in he
Autor:
Peter P. Gray, Karen Hughes, Martina L. Jones, Michael Gerometta, Stephen B. Lambert, Christopher C. Broder, Edwin P. Huang, Suzanne L. Elliott, Lin-Fa Wang, Benjamin S. Hughes, Dimiter S. Dimitrov, Stephen M. Mahler, Heidi J Carroll, Kathleen D. Lynch, Trent P. Munro, Mark G. Scher, Ina Smith, Paul M. Griffin, Reuben Klein, Margaret E. Gilmour, Christopher J. de Bakker, Debra El Saadi, E.G. Playford, Kym Hoger
Publikováno v:
SSRN Electronic Journal.
Background: The henipaviruses, Hendra virus and Nipah virus, are emerging zoonotic pathogens of bat origins that have been associated with poor clinical outcomes in humans. The monoclonal antibody (mAb) m102∙4 is a potent fully human antibody that
Publikováno v:
Journal of agricultural and food chemistry. 25(5)